User profiles for Bernd Neumaier
Bernd NeumaierInstitute of Neuroscience and Medicine INM-5: Nuclear Chemistry, Forschungszentrum … Verified email at uk-koeln.de Cited by 11579 |
Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG
…, G Glatting, T Mattfeldt, B Neumaier… - Journal of nuclear …, 2003 - Soc Nuclear Med
Recently, the thymidine analog 3′-deoxy-3′- 18 F-fluorothymidine (FLT) was suggested
for imaging tumoral proliferation. In this prospective study, we examined whether 18 F-FLT …
for imaging tumoral proliferation. In this prospective study, we examined whether 18 F-FLT …
[PDF][PDF] Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET
…, G Glatting, M Rentschler, B Neumaier… - Journal of Nuclear …, 1999 - Soc Nuclear Med
= 18F-fluorodeoxyglucose. whole-body â€@ †Iscintigraphy, †8F-fluorodeoxyglucose (FDG)
PET or radiography (reference methods are summarized in Table 1). MM (30 patients) or …
PET or radiography (reference methods are summarized in Table 1). MM (30 patients) or …
[HTML][HTML] Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
…, S Neubauer, A Drzezga, B Neumaier - Molecular Imaging and …, 2015 - Springer
Purpose Gallium-68 (Ga-68)-labeled tracers for imaging expression of the prostate-specific
membrane antigen (PSMA) such as the [ 68 Ga]Ga-PSMA-HBED-CC have already …
membrane antigen (PSMA) such as the [ 68 Ga]Ga-PSMA-HBED-CC have already …
Imaging prostate cancer with 11C-choline PET/CT
SN Reske, NM Blumstein, B Neumaier… - Journal of Nuclear …, 2006 - Soc Nuclear Med
The ability of 11 C-choline and multimodality fusion imaging with integrated PET and
contrast-enhanced CT (PET/CT) was investigated to delineate prostate carcinoma (PCa) within the …
contrast-enhanced CT (PET/CT) was investigated to delineate prostate carcinoma (PCa) within the …
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography
…, K Elsner, G Glatting, H Trager, B Neumaier… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: Previous studies have shown that bone metastases are revealed by magnetic
resonance imaging (MRI) or bone marrow scintigraphy several months before they are visible …
resonance imaging (MRI) or bone marrow scintigraphy several months before they are visible …
3-Deoxy-3-[18F]Fluorothymidine-Positron Emission Tomography for Noninvasive Assessment of Proliferation in Pulmonary Nodules
…, T Mattfeldt, F Liewald, SN Reske, B Neumaier - Cancer research, 2002 - AACR
We investigated whether uptake of the thymidine analogue 3-deoxy-3-[ 18 F]fluorothymidine
([ 18 F]FLT) reflects proliferation in solitary pulmonary nodules (SPNs). Thirty patients with …
([ 18 F]FLT) reflects proliferation in solitary pulmonary nodules (SPNs). Thirty patients with …
[HTML][HTML] Tumor VEGF: VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer
…, J Wolf, RA Brekken, B Neumaier… - The Journal of …, 2013 - Am Soc Clin Investig
The molecular mechanisms that control the balance between antiangiogenic and
proangiogenic factors and initiate the angiogenic switch in tumors remain poorly defined. By …
proangiogenic factors and initiate the angiogenic switch in tumors remain poorly defined. By …
Molecular imaging of proliferation in malignant lymphoma
…, D Bunjes, FM Mottaghy, BJ Krause, B Neumaier… - Cancer research, 2006 - AACR
We have determined the ability of positron emission tomography (PET) with the thymidine
analogue 3′-deoxy-3′-[ 18 F]fluorothymidine (FLT) to detect manifestation sites of malignant …
analogue 3′-deoxy-3′-[ 18 F]fluorothymidine (FLT) to detect manifestation sites of malignant …
[PDF][PDF] Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18) F] fluorodeoxyglucose and [(18) F] …
…, K Schulte, S Querings, E Stoelben, B Neumaier… - J Clin Oncol, 2011 - academia.edu
Purpose Positron emission tomography (PET) with both 2-deoxy-2-[18F] fluoro-D-glucose (FDG)
and 3-[18F] fluoro-3-deoxy-L-thymidine (FLT) was evaluated with respect to the …
and 3-[18F] fluoro-3-deoxy-L-thymidine (FLT) was evaluated with respect to the …
PSA-stratified performance of 18F-and 68Ga-PSMA PET in patients with biochemical recurrence of prostate cancer
…, BD Zlatopolskiy, B Neumaier… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Several studies outlined the sensitivity of 68 Ga-labeled PET tracers against the prostate-specific
membrane antigen (PSMA) for localization of relapsed prostate cancer in patients with …
membrane antigen (PSMA) for localization of relapsed prostate cancer in patients with …